131 related articles for article (PubMed ID: 10500576)
1. The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation.
Anguita A; Repetto HA; Rodriguez-Rilo L; Vazquez LA; Iturzaeta A; Morrone G; Deheza R; Maldonado L; Goldberg JL
Transplant Proc; 1999 Sep; 31(6):2279. PubMed ID: 10500576
[No Abstract] [Full Text] [Related]
2. Triple therapy with mycophenolate mofetil versus azathioprine.
Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
[No Abstract] [Full Text] [Related]
3. Mofetil mycophenolate in renal transplantation.
Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
[No Abstract] [Full Text] [Related]
4. A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
Thervet E; Morelon E; Ducloux D; Bererhi L; Noël LH; Janin A; Bedrossian J; Puget S; Chalopin JM; Mihatsch M; Legendre C; Kreis H
Transplant Proc; 2000 Dec; 32(8):2778. PubMed ID: 11134800
[No Abstract] [Full Text] [Related]
5. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Chenhsu RY; Wu YM; Min DI; Zimmerman MB
Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
[No Abstract] [Full Text] [Related]
6. Reduction in the incidence of early rejection in cadaveric renal allograft recipients treated with ATGAM induction and sequential mycophenolate mofetil.
Florence LS; Howard DR; Chapman PH; Lieberman J; Perkinson DT; Marks WH
Transplant Proc; 1997; 29(1-2):313-4. PubMed ID: 9123016
[No Abstract] [Full Text] [Related]
7. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
[No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil decreases the risk for chronic renal allograft failure.
Meier-Kriesche H; Ojo AO; Arndorfer JA; Magee JC; Cibrik DM; Leichtman AB; Campbell DA; Kaplan B
Transplant Proc; 2001; 33(1-2):1005-6. PubMed ID: 11267165
[No Abstract] [Full Text] [Related]
9. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
Miladipour AH; Ghods AJ; Nejadgashti H
Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil in renal transplantation: five years experience.
Tuncer M; Gürkan A; Erdoğan O; Demirbaş A; Süleymanlar G; Ersoy FF; Akaydin M; Yakupoğlu G
Transplant Proc; 2002 Sep; 34(6):2087-8. PubMed ID: 12270324
[No Abstract] [Full Text] [Related]
11. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Baker GM; Martin JE; Jang R; Schroeder TJ; Armitstead JA; Myre S; First MR
Transplant Proc; 1998 Dec; 30(8):4082-4. PubMed ID: 9865304
[No Abstract] [Full Text] [Related]
12. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
[No Abstract] [Full Text] [Related]
14. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
Elkhammas EA; Yilmaz S; Henry ML; Yenchar J; Bumgardner GL; Pelletier RP; Ferguson RM
Transplant Proc; 1998 Mar; 30(2):512. PubMed ID: 9532152
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
17. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.
Weber M; Ketchum RJ; Sellers M; Aradhye S; Deng S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
Transplant Proc; 1997; 29(1-2):338-9. PubMed ID: 9123029
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
Transplant Proc; 1997; 29(1-2):348-9. PubMed ID: 9123033
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
[No Abstract] [Full Text] [Related]
20. Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection.
Ferraris JR; Tambutti ML; Redal MA; Bustos D; Ramirez JA; Prigoshin N
Transplantation; 2000 Jul; 70(2):297-301. PubMed ID: 10933152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
